← Back to the fund page Use your browser's print dialog and choose “Save as PDF”. A4, two pages.
InvestVerdict

Tata Nifty MidSmall Healthcare Index Fund

Regular Plan · IDCW Payout Option · Index Funds · Scheme code 152562

Fund houseTata Mutual Fund
CategoryIndex Funds
Plan & optionRegular · IDCW Payout Option
History2.3 years

Returns (%)

 1M3M6M1Y3Y5Y7Y10YLaunch
This scheme 1.0510.1919.51 20.21 19.48
Nifty 100
benchmark
0.253.49-1.52 1.8410.529.38 12.79
Index Funds
category median
5.597.638.89 11.16

Over a year annualised (CAGR), under a year absolute. Computed from AMFI's published NAV history for this scheme.

Risk

 VolatilitySharpeSortinoBetaAlphaMax fall
This scheme 15.8% 0.82 1.17 0.73 15.26% -17.6% 39.67
Nifty 100
benchmark
17.1%0.23 0.32 -37.0%

Risk-free rate 6.5%. Beta, alpha and R² are regressed on the 28 months this scheme and its benchmark share.

Growth of ₹100 since launch

921131341562026InvestVerdict

Drawdown from peak (%)

0%-7%-13%-20%2026

Every one-year period it has lived through

WindowsWorstMedianBestPeriods that lost money
66 -2.1% 11.3% 25.0% 6%

Every one-year holding period in this scheme's history, not just the last one — the spread a real investor would have met depending only on when they started.

InvestVerdict

Tata Nifty MidSmall Healthcare Index Fund

Regular Plan · IDCW Payout Option

Allocation

By asset

Equity100.06%

By market cap

Mid Cap68.31%
Small Cap31.75%

Concentration

Number of stocks30
Top 5 stocks38.81%
Top 10 stocks60.20%
Top 20 stocks85.82%
Largest holding9.36%
Largest sectorPharmaceuticals & Biotechnology 77.53%
Effective stocks20.2
Cash-0.13%
InvestVerdict

Tata Nifty MidSmall Healthcare Index Fund

Regular Plan · IDCW Payout Option · holdings

Top 18 holdings

#CompanySector% of fund
1 Pharmaceuticals & Biotechnology9.36%
2 Pharmaceuticals & Biotechnology9.30%
3 Healthcare Services7.90%
4 Pharmaceuticals & Biotechnology6.99%
5 Pharmaceuticals & Biotechnology5.26%
6 Pharmaceuticals & Biotechnology5.17%
7 Pharmaceuticals & Biotechnology4.73%
8 Pharmaceuticals & Biotechnology4.56%
9 Pharmaceuticals & Biotechnology3.74%
10 Healthcare Services3.19%
11 Healthcare Services3.15%
12 Pharmaceuticals & Biotechnology3.15%
13 Pharmaceuticals & Biotechnology2.98%
14 Pharmaceuticals & Biotechnology2.69%
15 Pharmaceuticals & Biotechnology2.54%
16 Pharmaceuticals & Biotechnology2.54%
17 Pharmaceuticals & Biotechnology2.28%
18 Healthcare Services2.16%

Sector split

Pharmaceuticals & Biotechnology — 77.5%Healthcare Services — 21.5%Other — 1.0%Pharmaceuticals & Biotech…77.5%Healthcare Services21.5%Other1.0%
Pharmaceuticals & Biotechnology77.53%
Healthcare Services21.51%
Healthcare Equipment & Supplies1.02%

Not investment advice. InvestVerdict is not a SEBI-registered Investment Adviser or Research Analyst. Every figure is computed from AMFI's published NAV history and the portfolio the AMC filed with AMFI; none of it is a recommendation to buy, hold or sell. Past returns do not predict future ones. Generated 30 Aug 2026.